Now layer GLP-1 side effects on top: additional nausea, potential bloating , reduced appetite making it hard to consume the electrolytes and calories needed to manage keto adaptation, and potential fatigue from the medication itself
Mounjaro (tirzepatide) works on both GLP-1 and GIP receptors and has shown greater average weight loss in trials (around 21% on the highest dose over 72 weeks compared with 15% for Wegovy 2.4 mg, or 21% on the new Wegovy 7.2 mg dose)
J Am Coll Nutr 1986, 5: 177-182
Patients want results without risk, and TrimRx provides exactly that
Most people regain weight and lose metabolic benefits after stopping
Cardiovascular Benefits : It improves cholesterol, reduces inflammation, and may lower the risk of cardiovascular diseases, making it a holistic treatment option for metabolic health